March 17, 2020 / 3:18 PM / 20 days ago

BRIEF-Relief Therapeutics To Test Aviptadil For Treatment Of ARDS In Patients With Covid-19 Infection

March 17 (Reuters) - RELIEF THERAPEUTICS HOLDING SA :

* PLANS TO TEST AVIPTADIL FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME IN PATIENTS WITH COVID-19 INFECTION

* SAYS RLF-100 (AVIPTADIL)DEMONSTRATED CLINICAL BENEFIT IN PHASE I / II STUDIES IN PULMONARY ARTERIAL HYPERTENSION, SARCOIDOSIS AND ARDS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below